AveretteH.E., HoskinsW., NguyenH.N.: National survery of ovarian carcinoma: a patient care evaluation of the American College of Surgeons. Cancer, 71: 1629s–1638s, 1993.
2.
RiggsJ.E.: Rising ovarian cancer mortality in the elderly: A manifestation of differential survival. Gynecol Oncol, 58: 64–67, 1995.
3.
MonfardiniS.: Chemotherapy in the elderly: ECCO 7. The seventh European conference on clinical oncology and cancer nursing. Eur J Cancer, 29A: 13, 1993.
4.
GeislerJ.P., GeislerH.E.: Radical hysterectomy in patients 65 years of age and oldGynecol Oncol, 53: 208–211, 1994.
5.
GajewskiW.H., FullerA.F., LeyC.P.: Prognostic significance of DNA content in epithelial Ovarian Cancer. Gynecol Oncol, 53: 5–12, 1994.
6.
MarkmanM., LewisJ.L.Jr., SaigoP., HakesT., JonesW., RubinS., ReichmanB., BarakatR., CurtinJ., AlmadronesL., Morris-seyT., HoskinsW.: Epithelial ovarian cancer in the elderly: the Memorial Sloan-Kettering Cancer Center experience. Cancer, 71: 634–637, 1993.
7.
CornelisonT.L., ReedE.: Dose intensity analysis of high dose carboplatin in refractory ovarian carcinoma relative to age and clinical response. Proc AACR, 32: 1120, 1991.
8.
MarchettiD.L., LeleS.B., PrioreR.L., McPheeM.E., HreshchyshynM.M.: Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol, 49: 86–91, 1993.
9.
CapenC.V., BakerD.P.: Multidisciplinary management of the elderly patient with ovarian cancer. Clin Geriatr Med, 1: 345–358, 1985.
10.
BonettiA., FranceschiT., ApostoliP.: Cisplatin pharmacokinetics in elderly patients. The Drug Monitor, 16: 477–482, 1994.
11.
Ovarian cancer meta-analysis project:Cyclophosphamide, doxorubicin and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. J Clin Oncol, 9: 1668, 1991.
12.
YoungR.E.: Advanced ovarian adenocarcinoma: a prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med, 299: 1261, 1978.
13.
EdmonsonJ.H., SuJ., KrookJ.E.: Treatment of ovarian cancer in elderly women. Cancer, 71: 615–617, 1993.
14.
McGuireW.P., HoskinsW.J., BradyM.F.: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med, 334: 1–6, 1996.
15.
AlbertsD.S., GreenS., HanninganE.: Improved therapeutic index of carboplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol, 10: 706–717, 1992.
